WO2020163214A1 - Patient id and sample id workflow methods and apparatus for facilitating diagnostic testing - Google Patents
Patient id and sample id workflow methods and apparatus for facilitating diagnostic testing Download PDFInfo
- Publication number
- WO2020163214A1 WO2020163214A1 PCT/US2020/016352 US2020016352W WO2020163214A1 WO 2020163214 A1 WO2020163214 A1 WO 2020163214A1 US 2020016352 W US2020016352 W US 2020016352W WO 2020163214 A1 WO2020163214 A1 WO 2020163214A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diagnostic
- information
- consumable
- patient
- idm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/90—Identification means for patients or instruments, e.g. tags
- A61B90/94—Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text
- A61B90/96—Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text using barcodes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Definitions
- the present application relates to diagnostic testing, and more particularly to patient identification (ID) and sample ID workflow methods and apparatus for facilitating diagnostic testing.
- Point of care testing may be defined as medical diagnostic testing that is performed at a location where care or other treatment is provided. Point of care testing may also be referred to as near-patient testing, remote testing, satellite testing, and rapid diagnostics testing. Point of care test results may be made available relatively quickly so that they can be acted upon without delay. This increases the likelihood that the patient, physician, and care team will receive test results quicker, which allows for better and more immediate clinical management decisions to be made.
- a point of care system includes an instrument data manager (IDM) configured to communicate with a diagnostic engine, the IDM being configured to (1) obtain identification (ID) information of a patient for which a test is to be performed using the diagnostic engine; (2) obtain ID information of a diagnostic consumable to be used to collect a sample from the patient;
- IDDM instrument data manager
- the diagnostic engine to perform a test on the sample collected with the diagnostic consumable .
- a method of providing point of care diagnostic testing using a diagnostic engine includes employing an instrument data manager (IDM) to (1) obtain identification (ID) information of a patient for which a test is to be performed using the diagnostic engine; (2) obtain ID information of a diagnostic consumable to be used to collect a sample from the patient; and (3) link the obtained patient ID information with the obtained diagnostic consumable ID information.
- the method further includes restricting testing using the diagnostic engine by (4) prior to performing a test on a sample collected with a diagnostic consumable,
- determining ID information of the diagnostic consumable at the diagnostic engine (5) determining whether the diagnostic consumable is linked with patient ID information within the IDM; and (6) if the diagnostic consumable is linked with patient ID information within the IDM, allowing the diagnostic engine to perform a test on the sample collected with the diagnostic consumable.
- a method of providing point of care diagnostic testing using a diagnostic engine includes (1) obtaining identification (ID) information of a patient for which a test is to be performed using the diagnostic engine;
- the diagnostic engine to perform a test on the sample collected with the diagnostic consumable.
- a method of providing point of care diagnostic testing using a diagnostic engine includes (1) employing an instrument data manager (IDM) to obtain IDM.
- IDM instrument data manager
- ID identification
- a diagnostic consumable to be used to collect a sample from the patient
- linking the patient ID information with the diagnostic consumable ID information within the IDM prior to performing a test on a sample collected with a diagnostic consumable
- a) scanning ID information of the diagnostic consumable at the diagnostic engine prior to performing a test on a sample collected with a diagnostic consumable
- IDM configured to control operation of a plurality of diagnostic engines
- a display configured to control operation of a plurality of diagnostic engines
- a processor coupled to the display
- a memory coupled to the processor, the memory having stored therein a plurality of computer executable instructions that, when executed by the processor, cause the IDM to (a) provide a user interface through which the IDM obtains identification (ID) information for patients and ID information for diagnostic consumables;
- diagnostic consumable ID information received from the one or more of the plurality of diagnostic engines is not linked to patient ID information within the IDM.
- a method is provided that is performed by an instrument data manager (IDM) in communication with a plurality of diagnostic engines, the IDM being
- the method includes (1) obtaining, via a user interface of the IDM, identification (ID) information of a patient for which a test is to be performed; (2) obtaining, via the user interface of the IDM, ID information of a diagnostic consumable to be used to collect a sample from the patient; (3) linking, within the IDM, the obtained patient ID information with the obtained diagnostic consumable ID information; and (4) restricting testing using the plurality of diagnostic engines by (a) prior to allowing performance of a test on a sample collected with a diagnostic consumable within any of the plurality of diagnostic engines, receiving ID information of the diagnostic consumable from a diagnostic engine; (b) determining whether the diagnostic consumable ID information is linked with patient ID information within the IDM; and (c) if the diagnostic consumable ID information is linked with patient ID information within the IDM, allowing the diagnostic engine to perform the test on the sample collected with the diagnostic consumable.
- ID identification
- a point of care system includes (1) a diagnostic engine configured to perform a test on a sample and to generate a measured result based on the test on the sample; and (2) an instrument data manager (IDM) in electronic communication with the diagnostic engine, the IDM being configured to (a) obtain identification (ID) information of a patient for which a test is to be performed using the diagnostic engine; (b) obtain ID
- diagnostic consumable information of a diagnostic consumable to be used to collect a sample from the patient; (c) link the obtained patient ID information with the obtained diagnostic consumable ID information; and (d) restrict testing using the diagnostic engine by (i) prior to performing a test on a sample collected with a diagnostic consumable, determine ID information of the diagnostic consumable at the diagnostic engine; (ii) determine whether the diagnostic consumable is linked with patient ID information within the IDM; and (iii) if the diagnostic consumable is linked with patient ID information within the IDM, allow the diagnostic engine to perform a test on the sample collected with the diagnostic consumable.
- FIG. 1A illustrates an example point of care system provided in accordance with embodiments of the disclosure.
- FIG. IB illustrates an example diagnostic engine provided in accordance with embodiments of the disclosure.
- FIG. 2A illustrates an example data structure of patient information in accordance with embodiments of the disclosure .
- FIG. 2B illustrates an example data structure of diagnostic consumable information in accordance with
- FIG. 2C illustrates an example data structure in which patient ID information may be linked with diagnostic consumable ID information in accordance with embodiments of the disclosure.
- FIG. 3A illustrates an example method for collecting patient ID information and diagnostic consumable ID
- FIG. 3B illustrates an example method for ensuring patient ID information and diagnostic consumable ID
- FIGS. 4A-4P illustrate example display screen layouts during operation of the user interface of the
- instrument data manager of the point of care system of FIG. 1A in accordance with embodiments disclosed herein.
- test results must be accurately associated with the correct patient. This becomes more difficult in a busy clinical setting in which numerous tests are performed on many
- Embodiments provided herein help ensure that test results performed during point of care testing are associated with the correct patient (s) .
- Point of care testing may be defined as medical diagnostic testing that is performed at a location where care or other treatment is provided.
- a point of care system or device may be located, for example, in a hospital, nursing home, clinic, or in the home of an individual patient.
- Point of care testing may also be referred to herein as near-patient testing, remote testing, satellite testing, and/or rapid diagnostics testing.
- Example patient samples may include urine, blood, plasma, saliva, cerebrospinal fluid, pleural fluid, nasopharyngeal, or the like.
- Patient samples are collected using a diagnostic consumable which may include, for example, a sample cartridge or other sample container in which blood or another bodily fluid is stored, a urine cup, a test strip such as a urine or lateral flow strip, etc.
- a diagnostic consumable which may include, for example, a sample cartridge or other sample container in which blood or another bodily fluid is stored, a urine cup, a test strip such as a urine or lateral flow strip, etc.
- Such diagnostic consumables are typically, but need not be, one- time-use consumables.
- diagnostic engines used for testing may be controlled by a central interface unit, referred to as an instrument data manager (IDM) .
- IDM instrument data manager
- a point of care system may include one or more diagnostic engines controlled and/or interfaced with an IDM.
- the IDM may be employed to obtain identification (ID) information of a patient for which a test is to be performed.
- the IDM also may be used to obtain ID information of a diagnostic consumable to be used to collect and/or store a sample from the patient.
- the IDM may use a camera to image a barcode on a patient wrist band to obtain patient ID information and/or to image a barcode on the diagnostic consumable to obtain diagnostic consumable ID information.
- the IDM then links the patient ID information with the diagnostic
- the patient ID information and diagnostic consumable ID information may be linked together in a memory and/or database (or other data structure) within the IDM.
- Each patient to be tested using diagnostic engines may have one or more diagnostic consumables linked with the patient.
- patient ID information and diagnostic consumable ID information may be linked just prior to sample collection.
- ID information of the diagnostic consumable with the sample to be tested is scanned at the diagnostic engine.
- a barcode scanner within or near the diagnostic engine may be used to obtain the diagnostic consumable ID information.
- a camera or other scanner within the diagnostic engine may scan the diagnostic consumable as the diagnostic consumable is loaded into the diagnostic engine.
- This diagnostic consumable ID information is provided to the IDM, which determines whether the diagnostic consumable is linked with a patient (e.g., whether the scanned diagnostic consumable ID information is linked with patient ID
- the IDM allows the diagnostic engine to perform a test on the sample collected with the diagnostic consumable. If the diagnostic consumable ID information is not linked with patient ID information within the IDM, the IDM prevents the diagnostic engine from performing a test on the sample collected with the diagnostic consumable.
- a diagnostic consumable may be a cartridge or container which holds a sample and which is placed directly into a diagnostic engine.
- a diagnostic consumable may merely hold a sample prior to the sample being analyzed by a diagnostic engine.
- a urine cup may include a diagnostic consumable ID that is linked with patient ID information as described herein.
- the diagnostic consumable ID of the urine cup may be scanned to ensure that the urine cup is linked with patient information within the IDM prior to testing.
- a test strip may then be used to collect a portion of the sample from the urine cup for testing within the diagnostic engine.
- the test strip need not include a barcode or other ID information that is linked with patient information within the IDM.
- test strips may include diagnostic consumable ID information (e.g., a
- scannable barcode that must be linked with patient ID information before being analyzed with a diagnostic engine.
- a diagnostic consumable may include a vessel that retains a patient sample.
- a diagnostic consumable containing a sample may itself be inserted into a diagnostic engine for testing. In one or more other
- a diagnostic consumable may hold a sample prior to the use of another diagnostic consumable.
- a first diagnostic consumable may be a urine cup which holds a sample prior to application of a second diagnostic consumable such as a urine strip.
- the urine strip may then be analyzed by a diagnostic engine.
- each diagnostic consumable may include ID information (e.g., a scannable bar code) or a subset of the diagnostic consumables may include ID
- a diagnostic consumable may hold and provide a sample directly to a diagnostic engine.
- a blood gas analyzer may employ a needle to draw blood out of a diagnostic consumable (e.g., a syringe) .
- test results are known to be associated with the correct patient (s) .
- FIG. 1A illustrates an example point of care (POC) system 100 provided in accordance with embodiments of the disclosure.
- POC system 100 may include an IDM 102 in communication with one or more diagnostic engines 104a-n. Any number of diagnostic engines may be employed (e.g., 1, 2, 3, 5, 10, etc.).
- IDM 102 may include a processer 106 coupled to a memory 108, a camera 110 and a user interface 112.
- Processor 106 may be a computational resource such as, but not limited to, a microprocessor, a microcontroller, an embedded microcontroller, a digital signal processor (DSP), a field programmable gate array (FPGA) configured to perform as a microcontroller, or the like.
- DSP digital signal processor
- FPGA field programmable gate array
- Memory 108 may be any suitable type of memory, such as, but not limited to, one or more of a volatile memory and/or a non-volatile memory.
- memory 108 may include a combination of different types of memory such as volatile memory and non-volatile memory.
- Volatile memory may include, but is not limited to, a static random access memory (SRAM) , or a dynamic random access memory (DRAM) .
- Non-volatile memory may include, but is not limited to, an electrically programmable read-only memory (EPROM) , an electrically erasable programmable read-only memory (EEPROM) , a flash memory, etc.
- Memory 108 may have a plurality of instructions stored therein that, when executed by processor 106, cause processor 106 to perform various actions specified by one or more of the stored plurality of instructions.
- Camera 110 may include any suitable imaging device capable of imaging a barcode or other identifying information of a patient name tag (e.g., a wrist band), a diagnostic consumable, etc., as described further below.
- a patient name tag e.g., a wrist band
- diagnostic consumable e.g., a diagnostic consumable, etc.
- camera 110 may be a barcode reader in
- camera 110 may be a wireless (e.g., Bluetooth®, WIFI, or other wireless protocol) barcode reader.
- User interface 112 may include one or more of a display screen, a touch panel and/or screen, an audio speaker, and a microphone, for example.
- User interface 112 may be controlled by the IDM 102, and functionality of user interface 112 may be implemented, at least in part, by computer- executable instructions (e.g., program code or software) stored in memory 108 and/or executed by processor 106 of IDM 102.
- IDM 102 may receive one or more measured results from one or more diagnostic engines 102a-n, process the measured results to generate calculated results, and present the calculated results and/or other information, such as patient information, via user interface 112.
- user interface 112 may be configured to present one or more calculated results to a user of user interface 112.
- user interface 112 may be diagnostic engine agnostic, meaning that it may be able to present results associated with any number of diagnostic engines and any type of diagnostic engine. User interface 112 may allow multiple diagnostic engines to be operated at the same time and using the same interface. In one or more embodiments, a user of user interface 112 may be able to begin a test, enter or view patient information, enter login credentials, view the time remaining on a particular test, and/or view the calculated results based on a test performed by a given diagnostic engine 102a-n.
- User interface 112 may allow for common screens and elements between different types of diagnostic engines, improving efficiency of POC system 100 as a user of user interface 112 may only need to learn a single interface.
- specific instructions such as product specific instructions may be presented on user interface 112 which may be accessed from the single home screen .
- user interface 112 may display the status or calculated results of a test.
- User interface 112 may display the status or calculated results of multiple tests simultaneously. For example, if a user is running a urine test on a first patient and a blood test on a second patient, the user may be able to view one or more of the status or the calculated results of the urine test and the blood test on a single screen. This may be the case even when the urine test is being performed on a urinalysis diagnostic engine
- user interface 112 may be configured to simultaneously display calculated results associated with two different users of user interface 112. For example, user interface 112 may simultaneously display a blood test result for a first patient that was initiated by a first user of user interface 112 and a urine test result for the first patient or for a second patient that was initiated by a second user of user interface 112.
- IDM 102 may include one or more other components such as removable storage, a local printer, or the like (not shown) .
- Diagnostic engines 104a-n may perform one or more tests.
- diagnostic engines 104a-n may perform one or more tests to determine one or more characteristics of a sample, such as a bodily fluid sample.
- one or more diagnostic engines 104a-n may be a diabetes diagnostic engine configured to determine one or more
- characteristics of a blood sample such as an HbAlc level associated with the blood sample, or may be a urinalysis diagnostic engine configured to determine one or more
- characteristics of a urine sample such as the presence of one or more metabolites in that urine sample.
- Other diagnostic engines may be used.
- Each diagnostic engine 104a-n may include a
- diagnostic engine 104 coupled to a memory 116.
- a scanner 118 e.g., a camera, a barcode reader, etc.
- Other example components, that may be included in one or more of diagnostic engines 104a-n are illustrated in diagnostic engine 104 of FIG. IB (e.g., wireless circuitry 120, heating element 122, mixing means 124, optical sensor 126, pump 128, reagents 130 and/or the like) .
- diagnostic engines 104a-n may optionally comprise any number or any combination of these elements.
- a diagnostic engine may comprise multiple optical sensors 126 but may not comprise pump 128. It is further understood that a diagnostic engine 104a-n may comprise other components not shown in the figures or
- a first type of diagnostic engine e.g., a diabetes diagnostic engine
- a second type of diagnostic engine e.g., a urinalysis diagnostic engine
- Processor 114 may be a computational resource such as, but not limited to, a microprocessor, a microcontroller, an embedded microcontroller, a DSP, a FPGA configured to perform as a microcontroller, or the like.
- Memory 116 may be any suitable type of memory, such as but not limited to, one or more of a volatile memory and/or a non-volatile memory.
- memory 116 may include a combination of different types of memory such as volatile memory and non-volatile memory.
- Memory 116 may have a plurality of instructions stored therein that, when executed by processor 114, cause processor 114 to perform various actions specified by one or more of the stored plurality of instructions.
- Processor 114 may be configured to process a sample.
- processor 114 may be configured to receive an instruction from a user to perform a test on a sample (e.g., contained on or in a diagnostic consumable) inserted into a diagnostic engine 104a-n and to output one or more values representing a measured result of the test on that sample.
- processor 114 may be a real-time processor configured to generate one or more measurements within a given time period, such as ten seconds. Processor 114 may
- a non-real time processor configured to generate measured results based on the
- diagnostic engines 104a-n may comprise multiple processors, such as a real-time processor configured to obtain measurements in real-time and a non-real time processor configured to process the measurements to generate measured results .
- Processor 114 may control the various components of a diagnostic engine 104a-n (e.g., heating elements 122, mixing means 124, optical sensors 126, pumps 128, reagents 130, etc.,) and may receive feedback from those components.
- a diagnostic engine 104a-n e.g., heating elements 122, mixing means 124, optical sensors 126, pumps 128, reagents 130, etc.,
- Processor 114 may adjust one or more characteristics of a diagnostic engine 104a-n accordingly (in real-time) to keep the diagnostic engine 104a-n within the proper operating conditions and may obtain the measured results of a test performed by the diagnostic engine 104a-n.
- memory 116 of IDM 102 may be configured to store information received or generated by one or more of diagnostic engines 104a-n.
- memory 116 may be configured to store one or more values representing a measured result of a test performed by a diagnostic engines 104a-n.
- one or more diagnostic engines 104a-n may comprise limited processing and memory capabilities such that the diagnostic engine 104a-n is configured only to process a particular type of sample, store one or more values representing a measurement and/or measured result of the test on that sample in memory 116, and to send the measured results to IDM 102.
- Wireless circuitry 120 FIG.
- IB may enable a diagnostic engine 104a-n to communicate with one or more other components of POC system 100.
- wireless circuitry 120 may enable a diagnostic engine 104a-n to communicate measured results over a Bluetooth® or WiFi connection to IDM 102 (which may also include wireless circuitry, not separately shown) .
- the information may additionally or alternatively be communicated to a printer, an informatics management program, or any other type of information system (not separately shown) .
- one or more of diagnostic engines 104a-n may comprise one or more components which may be in communication with processor 114 and which may be controlled by processor 114.
- a diagnostic engine 104a-n may comprise one or more of heating element 122 configured to heat a test sample, mixing means 124 configured to mix one or more components of the test sample, optical sensor 126 configured to determine one or more optical characteristics of the test sample, and pump 128 configured to move at least a portion of the sample from one location to another in the diagnostic engine 104a-n.
- diagnostic engines 104a-n may contain not only the physical components (e.g., heating element 122, mixing means 124, optical sensor 126, pump 128, reagent 130 and/or the like), but may also control the series of steps in which use of those components are utilized to obtain a measured result.
- a diabetes diagnostic engine may mix a sample using mixing means 124, heat the sample to a desired temperature (e.g., 80 degrees Celsius) using the heating element 122, mix the sample a second time using mixing means 124, and take an optical reading of the sample using optical sensor 126.
- Each diagnostic engines 104a-n may be configured to receive a sample in the form of a diagnostic consumable (e.g., a sample cartridge in which blood or another bodily fluid is stored, a test strip such as a urine or lateral flow strip, etc.) .
- a diagnostic engine may be configured to come into direct contact with the sample during the test. Examples of these types of diagnostic engines include so called "bench top" blood gas analyzers (such as the RapidPoint 500, sold by Siemens Healthcare Diagnostics Inc., of Tarrytown, NY) and automated urine chemistry analyzers (such as the Clinitek Novus, sold by Siemens Healthcare Diagnostics Inc. of
- a diagnostic engine 104a-n may not come into contact with the sample directly, but rather indirectly (e.g., optically) .
- a sample may be obtained from a patient using any one or a combination of methods known in the art.
- a syringe can be used to withdraw blood from a vein of the patient.
- the blood sample can be separated (e.g., by centrifugation) to isolate and obtain a serum sample.
- a blood sample can additionally or optionally be obtained by lightly pricking one of the subject's fingers (e.g., with a sterile needle) and then collecting a desired volume of blood.
- a diagnostic consumable configured to be received by a given one of diagnostic engines 104a-n.
- a diagnostic consumable may be a plastic or glass container configured to receive a certain volume of the sample, or may be a test strip configured to receive a minor amount of the sample. It is understood that a diagnostic consumable may comprise any type of container configured to receive any volume of a sample capable of being inserted into a diagnostic engine 104a-n.
- Bodily fluids capable of being tested by one or more of diagnostic engines 104a-n include but are not limited to urine, blood, plasma, saliva, cerebrospinal fluid, pleural fluid, nasopharyngeal, and the like. Blood samples may be routinely analyzed to obtain measurements of the partial pressures of CO2 and O2 and/or concentrations of electrolytes and/or metabolites in the blood. A number of different diagnostic engines may be provided for making such
- Such sensor assemblies may be used to assess the condition of medical patients through primary clinical indications, for example, through monitoring of pCC>2, p0 2 , pH, Na+, K+, Ca 2 +, C1-, glucose, lactate, and hemoglobin values.
- pCC>2 p0 2 , pH, Na+, K+, Ca 2 +, C1-, glucose, lactate, and hemoglobin values.
- the samples are not limited to these types of samples and that diagnostic engines 104a-n may be configured to process any types of samples.
- a diagnostic engine 104a-n may include a chemical sensor.
- a diagnostic engine 104a-n may comprise a chemical surface, an integrated circuit structure, a micro electromechanical structure, an optical sensor, or another device responsive to chemical characteristics, such as a chemical type, blood gas level, pH level, existence of a particular chemical, amount of a particular chemical, or other characteristics.
- a diagnostic engine 104a-n may comprise a chemical or biological recognition element with or without a permeable membrane and a signal transducer element, such as electrochemical (amperometry or potentiometry) , electrical (ion-sensitive field effect transistor,
- An amplification or processing element may be integrated with an analyte responsive
- a biological recognition phase enzyme, antibody, receptor, DNA or other chemical
- a biological recognition phase may interact with the analyte of interest to produce a charge or optical change at the sensor-transducer interface or
- any now known or later developed chemical sensors such as immunosensors , optrodes, chemical canaries, resonant mirrors, glucometers, biochips, and/or biocomputers, may be used .
- POC system 100 may comprise multiple diagnostic engines 104a-n and/or multiple different types of diagnostic engines 104a-n.
- POC system 100 may comprise a first diagnostic engine 104a configured for testing a first type of sample (e.g., a blood sample) and a second diagnostic engine 104b configured for testing a second type of sample (e.g., a urine sample) .
- POC system 100 may comprise any number of diagnostic engines 104a-n for testing any number of different types and combinations of samples.
- diagnostic engines 104a-n include but are not limited to blood gas diagnostic engines, cardiac diagnostic engines,
- a blood gas diagnostic engine may be configured to receive a blood sample and to determine one or more
- a blood gas diagnostic engine may be configured to measure one or more of hydrogen ions (pH) , partial pressure of carbon dioxide (pC0 2 ) and partial pressure of oxygen (PO2) in a blood sample.
- the blood gas diagnostic engine may also be configured to measure for the presence and/or concentration of electrolytes and metabolites in the blood sample.
- a cardiac diagnostic engine may be configured to receive a sample and measure one or more cardiac health markers.
- the cardiac diagnostic engine may receive a blood sample and may be configured to measure one or more of total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, non-HDL cholesterol, and high-sensitivity C- reactive protein in the blood sample.
- the cardiac diagnostic engine may be configured to test for and/or measure troponin levels in the blood sample.
- a coagulation diagnostic engine may be configured to receive a blood sample and to measure one or more blood clotting characteristics.
- the coagulation diagnostic engine may perform one or more of the following tests: Prothrombin time (PT), Activated Partial Thromboplastin Time (APTT), and Activated Clotting Time (ACT) .
- the coagulation diagnostic engine may apply a chemical membrane to one or more electrodes in a reaction chamber which may create thrombin in the blood sample.
- An activator may also be present to accelerate the creation of thrombin in the sample.
- a diabetes diagnostic engine may be configured to measure one or more diabetes markers in a sample.
- the diabetes diagnostic engine may measure a patient' s HbAlc levels using a monoclonal antibody
- the diabetes diagnostic engine may be configured to test Albumin levels in the blood sample using an apolyclonal goat anti human albumin antiserum and to test the creatinine level of the sample using a Benedict Behre chemical reaction.
- IDM 102 may compute a ratio of the Albumin level to the creatinine level in the blood sample.
- a urinalysis diagnostic engine may be configured to receive a urine sample and to test for one or more
- Example methodologies may include the use of chromatographic detection pads,
- colorimetric reagent pads (which may change color depending on the concentration of the analyte in the blood)
- optical testing systems in which an image of the urine is put under a microscope and an image recognition algorithm identifies substances in the sample.
- POC system 100 shown in FIG. 1A may comprise any number and any combination of types of different diagnostic engines 104a-n.
- Each diagnostic engines 104a-n may be configured to receive a test sample, perform a test on the sample, and to send a measured result of that test to IDM 102.
- Each diagnostic engine 104a-n may also be
- IDM 102 may be configured to receive as input one or more measured results from one or more of diagnostic engines 104a-n. The measured results may be received, for example, over a communications connection 132 between the one or more diagnostic engines 104a-n and IDM 102.
- connection 132 may comprise a wireless connection.
- connection 132 may comprise a Bluetooth® connection.
- connection 132 may be any type of wireless connection, such as a ZigBee connection, a WiFi connection, or the like.
- connection 132 may comprise a hardwired connection. Connection 132 may be made via a USB cable or any other suitable communication cable interface technology.
- the measured result may comprise one or more values that represent a measured result of the test performed by a diagnostic engine 104a-n.
- IDM 102 may receive a single value from a diabetes diagnostic engine representing an HbAlc value of a blood sample or may receive multiple values from a cardiac diagnostic engine corresponding to total cholesterol, DDL cholesterol, HDD cholesterol, and triglycerides levels of the blood sample.
- IDM 102 may be configured to communicate information to any diagnostic engines 104a-n, such as an instruction to initiate a test, software updates, or changes to the
- diagnostic engine protocol that may be used by processor 114 of the diagnostic engine 104a-n in generating one or more test results. Control of diagnostic engines 104a-n themselves may be performed by the processors 114 associated with the diagnostic engines 104a-n and/or instructions received from one or more users at diagnostic engines 104a-m.
- Processor 106 of IDM 102 may perform a variety of higher-level processing functions of POC system 100. Such higher-level functions may be performed by executing computer- executable instructions (e.g., program code) stored in a computer-readable medium, such as memory 108.
- IDM 102 may comprise any suitable computing device, such as a tablet computer, laptop computer, desktop computer, personal digital assistant, or other stationary or hand-held computing device.
- processor 106 upon receiving a measured result from a diagnostic engine 104a-n, may be configured to process the measured result so that a calculated result may be presented to a user of POC system 100.
- IDM 102 may receive one or more values (e.g., measured results) from a diagnostic engine 104a-n.
- Processor 106 may be configured to determine which values correspond to certain health markers and may determine how to present those values to a user of POC system 100.
- Processor 106 may be configured to generated calculated results by comparing a received value to one or more other stored or received values and may be configured to compute a ratio of one value to another, such as a triglyceride to HDD cholesterol ratio of a blood sample, in order to generate calculated results.
- processor 106 may be a non-real time processor configured to convert measurements received from a diagnostic engine 104a-n into calculated results capable of being displayed to a user (e.g., via user interface 112) .
- processor 106 may be configured to receive one or more measured results from processor 114 of a
- FIG. 3A illustrates an example method 300 for collecting patient ID information and diagnostic consumable ID information, and linking patient ID information and diagnostic consumable ID information within IDM 102 in accordance with embodiments disclosed herein
- FIG. 3B illustrates an example method 310 for ensuring patient ID information and diagnostic consumable ID information are linked within IDM 102 before allowing testing with any diagnostic engine 104a-n in accordance with embodiments disclosed herein
- FIGS. 4A-4P illustrate example display screen layouts during operation of user interface 112 of IDM 102 within POC system 100 of FIG. 1A in accordance with embodiments disclosed herein.
- method 300 may be performed by POC system 100 and includes obtaining ID
- method 300 may be performed immediately prior to a sample being collected from a patient (e.g., prior to a blood draw, finger prick, urine collection, etc.) .
- Diagnostic consumable ID information similarly may be entered into IDM 102 and stored in memory 108.
- diagnostic consumable ID information may be entered manually through user interface 112 of IDM 102.
- camera 110 of IDM 102 may scan diagnostic consumable ID information into IDM 102 for storage into memory 108, such as by scanning a barcode on a sample cartridge, urine (sample) cup, test strip or other diagnostic consumable.
- An example diagnostic consumable 138 is shown in FIG. 1A that includes a barcode 140 encoded with diagnostic consumable ID information.
- diagnostic consumable 138 may be scanned by camera 110 or another imaging device to obtain diagnostic consumable ID information for storage in memory 108 of IDM 102.
- Example diagnostic consumable ID information includes a diagnostic consumable ID number, the type of test to be performed on the diagnostic consumable, the time the diagnostic consumable ID was scanned, calibration information, expiration date, lot number, or the like.
- a patient may be providing samples for testing using many different diagnostic engines.
- the sample in the form of a diagnostic consumable
- the sample may be transferred to a diagnostic engine along with other patient samples.
- a large queue of samples e.g., diagnostic consumables
- method 310 may be performed by POC system 100 once sample testing is to be performed, such as after sample collection.
- method 310 may include obtaining ID information for the diagnostic consumable having the sample to be tested (Block 312), and confirming the diagnostic consumable is valid (Block 314) .
- a barcode scanner such as scanner 118 of one of diagnostic engines 104a-n of FIG. 1A, may be used to scan a barcode on the diagnostic consumable to determine its diagnostic consumable ID information.
- inserting a diagnostic consumable into a diagnostic engine for testing may cause a barcode on the diagnostic consumable to be scanned.
- a separate barcode scanner that is part of or separate from the diagnostic engine may be used to obtain diagnostic consumable ID information. The diagnostic engine may then provide the scanned diagnostic consumable ID information to IDM 102.
- IDM 102 receives ID information for a
- IDM 102 may determine if the diagnostic consumable is valid. For example, IDM 102 may determine if the ID number for the diagnostic consumable is a valid ID number, corresponds to a proper type of diagnostic consumable for the diagnostic engine being used, etc. If not, method 310 ends (Block 316) ; otherwise method 310 includes determining if the diagnostic consumable ID information is linked with patient ID information within IDM 102 (Block 318) . For example, IDM 102 may access memory 108 to determine if the diagnostic
- the diagnostic engine may be prevented (or otherwise restricted or limited) from testing the sample collected with the diagnostic consumable and method 310 ends (Block 316) ; otherwise, if the diagnostic consumable ID information is linked or otherwise associated with patient ID information, IDM 102 allows the diagnostic engine to perform testing on the sample collected with the diagnostic consumable (Block 320) .
- IDM 102 may issue an instruction to the diagnostic engine indicating that the diagnostic engine should commence testing. Following testing, test results from the diagnostic engine may be communicated to IDM 102 and/or stored with patient ID information as described below.
- FIGS. 4A-4P illustrate example display screen layouts 400a-p displayed by user interface 112 of IDM 102 of FIG. 1A during testing of a sample collected with a diagnostic consumable in accordance with embodiments provided herein.
- Display screens layouts 400a-p of FIGS. 4A-4P are merely examples. Other screen layouts, icons, information, order of screen layouts, content and/or the like may be employed.
- Example user authentication information may include an operator ID and password, information contained within an employee badge with a scannable barcode, information contained within a radio-frequency identification (RFID) tag, two-factor authentication information such as a password and a one-time code sent via text, email, or a smart phone application, etc.
- a user may input operator ID information by scanning a barcode (e.g., on a name tag, wrist band, etc.) .
- a barcode e.g., on a name tag, wrist band, etc.
- camera 110 of IDM 102 or another imaging device may be employed to scan a barcode to provide operator ID information to IDM 102.
- operator ID information may be entered manually (e.g., via a keyboard, touch screen, or the like) .
- IDM 102 may be used to collect patient ID information (FIG. 4C) that is associated with a diagnostic consumable (FIG. 4D) .
- patient ID information may be manually entered into IDM 102, scanned using camera 110 or another imaging device, or otherwise provided to IDM 102.
- patient information may be obtained from a previously stored list or database of patient information (e.g., data structure 200 of FIG. 2A) .
- Patient information may be stored in memory 108 of IDM 102, for example, such as in data structure 200 (FIG. 2A) .
- IDM 102 may link patient ID information with diagnostic consumable ID information.
- patient ID information and diagnostic consumable ID information may be stored in memory 108 of IDM 102, such as in data structure 204 of FIG. 2C.
- a sample may be collected from the patient using the diagnostic consumable and the diagnostic consumable may be sent for testing by one of diagnostic engines 104a-n.
- a urine, blood, plasma, saliva, cerebrospinal fluid, pleural fluid For example, a urine, blood, plasma, saliva, cerebrospinal fluid, pleural fluid,
- diagnostic consumable when the diagnostic consumable is inserted into the diagnostic engine.
- another imaging device internal or external to the diagnostic engine may be employed to scan a barcode on the diagnostic
- diagnostic consumable ID information may be manually entered via a keyboard, touch screen, etc. Scanned (or otherwise obtained) diagnostic consumable ID information is then communicated by the
- IDM 102 diagnostic engine to IDM 102, such as via connection 132 (FIG. 1A) .
- user interface 112 may instruct the technician to load the diagnostic consumable into the
- user interface 112 may instruct the technician to prepare the diagnostic consumable for testing, such as by removing a sealing tab, cover, or the like, as shown in display screen layout 400h of FIG. 4H, and/or prepare the diagnostic engine for testing, such as by closing a lid or cover the diagnostic engine, as shown in display screen layout 400i of FIG. 41.
- testing may begin as shown in display screen layout 400j of FIG. 4J.
- IDM 102 or the diagnostic engine being used may initiate testing.
- user interface 112 may display the type of test being performed (e.g., an HbAlC measurement in FIG. 4J) , how long the test has been running, how much time is remaining, etc .
- measured results may be communicated from the diagnostic engine to IDM 102.
- IDM 102 may receive one or more measured results from a diagnostic engine, process the measured results to generate calculated results, and present the calculated results and other information such as patient information via user interface 112 as shown in display screen layout 400k of FIG. 4K.
- the diagnostic engine may provide calculated results to IDM 102 for display via user interface 112.
- user interface 112 may allow a user to print results, comment on results, etc.
- user interface 112 may indicate that the diagnostic consumable should not be removed, as shown in display screen layout 4001 of FIG. 4L. Likewise, if the diagnostic consumable is ready to be removed from the diagnostic engine in which it is tested, user interface 112 may indicate that the diagnostic consumable may be removed, as shown in display screen layout 400m of FIGS. 4M. In some embodiments, user interface 112 may provide step-by-step instructions for removing the diagnostic consumable, such as raising the lid or cover the diagnostic engine (FIG.
- test results are properly associated with the correct patient (s) .
- POC system 100 and any of the components described herein may be part of an "open system.”
- IDM 102 may be configured to connect and
- IDM 102 may be configurable to download or install new software that enables IDM 102 to communicate with the variety of diagnostic engines.
- user interface 112 may comprise an icon that enables one or more new diagnostic engines to be added to IDM 102.
- a given diagnostic engine may only be controllable by a single IDM 102.
- a diagnostic engine may be controllable by a plurality of IDMs 102.
- a diagnostic engine 104a-n may be developed by an external partner of the
- a diagnostic engine 104a-n may be a virtual engine that works in cooperation with the hardware and software of other external devices. In an example, this could be a blood pressure monitor that allows IDM 102 to combine results from a blood pressure monitor with other measured or calculated results to generate new calculated results.
- diagnostic engine 104a-n may be a virtual engine that comprises only an application that can obtain and manipulate data. For example, the diagnostic engine may submit a
- diagnostic engines may not include a user interface.
- communication to/from a diagnostic engine may be performed through user interface 112 of IDM 102, for example.
- a method of providing point of care diagnostic testing using a diagnostic engine comprising:
- IDM instrument data manager
- the diagnostic consumable is linked with patient ID information within the IDM, allowing the diagnostic engine to perform a test on the sample collected with the diagnostic consumable.
- information for the diagnostic consumable includes using the diagnostic engine to scan a barcode of the diagnostic
- the interface with a plurality of diagnostic engines; and for two or more of the plurality of diagnostic engines, prior to testing a sample collected with a diagnostic consumable using any of the two or more of the plurality of diagnostic engines, confirm at the diagnostic engine that the diagnostic consumable is linked with patient ID information prior to allowing testing with the diagnostic engine.
- the plurality of diagnostic engines comprise at least one of a blood gas diagnostic engine, a cardiac diagnostic engine, a coagulation diagnostic engine, a diabetes diagnostic engine, and a urinalysis diagnostic engine.
- IDM instrument data manager
- IDM employing the IDM to scan ID information of a diagnostic consumable to be used to collect a sample from the patient ;
- the diagnostic engine confirming that the diagnostic consumable is linked with the patient ID information within the IDM; and if the diagnostic consumable is linked with the patient ID information within the IDM, directing the diagnostic engine to perform a test on the sample collected with the diagnostic consumable.
- diagnostic engine from performing a test on the sample collected with the diagnostic consumable.
- An instrument data manager configured to control operation of a plurality of diagnostic engines comprising :
- a processor coupled to the display
- a memory coupled to the processor, the memory having stored therein a plurality of computer executable instructions that, when executed by the processor, cause the IDM to:
- ID identification
- diagnostic consumables a user interface through which the IDM obtains identification (ID) information for patients and ID information for diagnostic consumables
- IDM IDM. [ 00111 ] 16. The IDM of claim 15, wherein the memory includes computer executable instructions that direct the processor to link patient ID information and diagnostic consumable ID information in a database.
- identification (ID) information of a patient for which a test is to be performed obtaining, via a user interface of the IDM, identification (ID) information of a patient for which a test is to be performed;
- the diagnostic consumable is not linked with patient ID information within the IDM, preventing the diagnostic engine from performing a test on the sample collected with the diagnostic consumable.
- a point of care system comprising:
- a diagnostic engine configured to perform a test on a sample and to generate a measured result based on the test on the sample
- IDM instrument data manager
- ID identification
- the diagnostic engine if the diagnostic consumable is linked with patient ID information within the IDM, allow the diagnostic engine to perform a test on the sample collected with the diagnostic consumable.
- the diagnostic consumable is not linked with patient ID information within the IDM, prevent the diagnostic engine from performing a test on the sample collected with the diagnostic consumable.
- the diagnostic engine is configured to scan barcodes of diagnostic consumables to determine diagnostic consumable ID information for each diagnostic consumable and communicate sample ID information to the IDM.
- the diagnostic engine includes a barcode scanner that allows an operator to scan a barcode of a diagnostic consumable before the diagnostic consumable is inserted into the
- the point of care system of claim 20 wherein the IDM is configured to communicate with the diagnostic engine via wireless communications.
- the diagnostic engine is configured to analyze samples collected with diagnostic consumables that include a urine sample cup or a sample cartridge.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
Claims
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/310,236 US12167945B2 (en) | 2019-02-06 | 2020-02-03 | Patient ID and sample ID workflow methods and apparatus for facilitating diagnostic testing |
| MX2021009176A MX2021009176A (en) | 2019-02-06 | 2020-02-03 | Patient id and sample id workflow methods and apparatus for facilitating diagnostic testing. |
| JP2021545817A JP7241189B2 (en) | 2019-02-06 | 2020-02-03 | Method and Apparatus for Patient ID and Sample ID Workflow to Facilitate Diagnostic Testing |
| CA3128979A CA3128979A1 (en) | 2019-02-06 | 2020-02-03 | Patient id and sample id workflow methods and apparatus for facilitating diagnostic testing |
| AU2020219731A AU2020219731A1 (en) | 2019-02-06 | 2020-02-03 | Patient ID and sample ID workflow methods and apparatus for facilitating diagnostic testing |
| EP20752748.2A EP3921840A4 (en) | 2019-02-06 | 2020-02-03 | METHODS AND WORKFLOW APPARATUS FOR PATIENT AND SPECIMEN IDENTIFICATION TO FACILITATE DIAGNOSTIC TESTING |
| US29/779,118 USD984466S1 (en) | 2019-02-06 | 2021-04-16 | Portion of a display screen with a graphical user interface having a progress indicator |
| US29/779,125 USD984467S1 (en) | 2019-02-06 | 2021-04-16 | Portion of a display screen with a graphical user interface having a progress indicator |
| US29/779,114 USD993981S1 (en) | 2019-02-06 | 2021-04-16 | Portion of a display screen with a graphical user interface having a progress indicator |
| US29/779,112 USD993967S1 (en) | 2019-02-06 | 2021-04-16 | Portion of a display screen with a graphical user interface having a progress indicator |
| US18/935,821 US20250057632A1 (en) | 2019-02-06 | 2024-11-04 | Patient id and sample id workflow methods and apparatus for facilitating diagnostic testing |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962801942P | 2019-02-06 | 2019-02-06 | |
| US62/801,942 | 2019-02-06 |
Related Child Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/310,236 A-371-Of-International US12167945B2 (en) | 2019-02-06 | 2020-02-03 | Patient ID and sample ID workflow methods and apparatus for facilitating diagnostic testing |
| US29/779,114 Continuation-In-Part USD993981S1 (en) | 2019-02-06 | 2021-04-16 | Portion of a display screen with a graphical user interface having a progress indicator |
| US29/779,125 Continuation-In-Part USD984467S1 (en) | 2019-02-06 | 2021-04-16 | Portion of a display screen with a graphical user interface having a progress indicator |
| US29/779,112 Continuation-In-Part USD993967S1 (en) | 2019-02-06 | 2021-04-16 | Portion of a display screen with a graphical user interface having a progress indicator |
| US29/779,118 Continuation-In-Part USD984466S1 (en) | 2019-02-06 | 2021-04-16 | Portion of a display screen with a graphical user interface having a progress indicator |
| US18/935,821 Continuation US20250057632A1 (en) | 2019-02-06 | 2024-11-04 | Patient id and sample id workflow methods and apparatus for facilitating diagnostic testing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2020163214A1 true WO2020163214A1 (en) | 2020-08-13 |
Family
ID=71947117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2020/016352 Ceased WO2020163214A1 (en) | 2019-02-06 | 2020-02-03 | Patient id and sample id workflow methods and apparatus for facilitating diagnostic testing |
Country Status (7)
| Country | Link |
|---|---|
| US (6) | US12167945B2 (en) |
| EP (1) | EP3921840A4 (en) |
| JP (1) | JP7241189B2 (en) |
| AU (1) | AU2020219731A1 (en) |
| CA (1) | CA3128979A1 (en) |
| MX (1) | MX2021009176A (en) |
| WO (1) | WO2020163214A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022207108A1 (en) * | 2021-03-31 | 2022-10-06 | Cg Test Gmbh | Method for evaluating a test result of a medical test means |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD1063953S1 (en) * | 2019-08-23 | 2025-02-25 | Bionime Corporation | Screen with graphical user interface |
| USD1005303S1 (en) * | 2020-01-28 | 2023-11-21 | Iocurrents, Inc. | Display screen or portion thereof with animated graphical user interface |
| USD1066353S1 (en) * | 2020-12-18 | 2025-03-11 | Tianning Han | Display screen or portion thereof with animated graphical user interface |
| JP1725302S (en) * | 2021-02-23 | 2022-09-21 | GUI | |
| USD1029000S1 (en) * | 2021-03-09 | 2024-05-28 | Huawei Technologies Co., Ltd. | Display screen or portion thereof with animated graphical user interface |
| USD1015341S1 (en) * | 2021-06-05 | 2024-02-20 | Apple Inc. | Display or portion thereof with graphical user interface |
| USD999778S1 (en) * | 2021-08-12 | 2023-09-26 | Hewlett Packard Enterprise Development Lp | Display with graphical user interface for surfacing action items |
| USD1023027S1 (en) * | 2021-09-15 | 2024-04-16 | 10X Genomics, Inc. | Display screen or portion thereof with transitional graphical user interface |
| USD1019675S1 (en) * | 2021-10-29 | 2024-03-26 | Medtrum Technologies Inc. | Display screen or portion thereof with graphical user interface |
| USD1019674S1 (en) * | 2021-10-29 | 2024-03-26 | Medtrum Technologies Inc. | Display screen or portion thereof with graphical user interface |
| USD1027997S1 (en) * | 2022-01-14 | 2024-05-21 | Kilburn Live, Llc | Display screen or portion thereof with graphical user interface |
| USD1098124S1 (en) | 2022-04-14 | 2025-10-14 | 10X Genomics, Inc. | Display screen or portion thereof with transitional graphical user interface |
| USD1038148S1 (en) * | 2022-07-14 | 2024-08-06 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with transitional graphical user interface |
| USD1092498S1 (en) * | 2022-07-14 | 2025-09-09 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with transitional graphical user interface |
| USD1044836S1 (en) | 2022-09-29 | 2024-10-01 | Aristocrat Technologies Australia Pty Limited | Display screen or portion thereof with graphical user interface |
| USD1044861S1 (en) * | 2022-09-29 | 2024-10-01 | Aristocrat Technologies Australia Pty Limited | Display screen or portion thereof with transitional graphical user interface |
| WO2024086700A1 (en) * | 2022-10-20 | 2024-04-25 | In Vitro Diagnostic Solutions | Capture and use of results for diagnostic assays via point-of-collection devices using mobile devices |
| USD1109160S1 (en) * | 2022-11-15 | 2026-01-13 | Block, Inc. | Display screen or portion thereof with a graphical user interface |
| EP4670172A1 (en) * | 2023-02-20 | 2025-12-31 | Siemens Healthcare Diagnostics, Inc. | METHOD AND DEVICE FOR AVOIDING PATIENT AND SAMPLE MISCATCHES DURING DIAGNOSTIC TESTS |
| USD1094401S1 (en) * | 2023-02-20 | 2025-09-23 | Sony Interactive Entertainment Inc. | Display screen or portion thereof with transitional graphical user interface |
| USD1119926S1 (en) | 2023-05-12 | 2026-03-24 | Etn Capital, Llc | Display screen or portion thereof with a graphical user interface |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090227897A1 (en) * | 2004-12-09 | 2009-09-10 | Koninklijke Philips Electronics N.V. | Patient identification for point of care diagnostics |
| US20130080071A1 (en) * | 2011-09-25 | 2013-03-28 | Theranos, Inc., a Delaware Corporation | Systems and methods for sample processing and analysis |
| US20150209114A1 (en) * | 2014-01-29 | 2015-07-30 | Becton, Dickinson And Company | System and Method for Collection Confirmation and Sample Tracking at the Clinical Point of Use |
| US20160321421A1 (en) * | 2015-05-02 | 2016-11-03 | Roche Diagnostics Operations, Inc. | Point-of-care testing system |
| US20170021349A1 (en) | 2014-11-11 | 2017-01-26 | Genmark Diagnostics, Inc. | Redundant identification for sample tracking on a diagnostic device |
| US20170220775A1 (en) * | 2001-11-13 | 2017-08-03 | Dako Denmark A/S | System for tracking biological samples |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD497617S1 (en) | 2001-05-16 | 2004-10-26 | Groxis, Inc. | Graphical information interface for a display |
| EP1436586A2 (en) * | 2001-10-19 | 2004-07-14 | MonoGen, Inc. | Automated system and method for processing multiple liquid-based specimens |
| US20050060188A1 (en) * | 2003-09-03 | 2005-03-17 | Electronic Data Systems Corporation | System, method, and computer program product for health care patient and service management |
| JP4500749B2 (en) * | 2005-09-05 | 2010-07-14 | 株式会社日立ハイテクノロジーズ | Automatic analyzer |
| US20070233035A1 (en) * | 2006-03-28 | 2007-10-04 | Hospira, Inc. | Medication administration and management system and method |
| JP2008281394A (en) * | 2007-05-09 | 2008-11-20 | Olympus Corp | Automatic analyzer |
| JP5455107B2 (en) * | 2008-11-07 | 2014-03-26 | 株式会社イードクトル | Blood collection support system that does not require connection to a host computer |
| JP5452122B2 (en) * | 2009-08-04 | 2014-03-26 | シスメックス株式会社 | Specimen test apparatus, test information management apparatus, and test information output method |
| JP5432816B2 (en) * | 2010-05-14 | 2014-03-05 | 株式会社日立ハイテクノロジーズ | Automatic analysis system and device management server |
| JP5606875B2 (en) * | 2010-10-29 | 2014-10-15 | シスメックス株式会社 | Sample processing apparatus and computer program |
| USD698363S1 (en) | 2010-12-28 | 2014-01-28 | Sony Corporation | Display screen with a graphical user interface |
| US8549600B2 (en) | 2011-03-11 | 2013-10-01 | Abbott Point Of Care Inc. | Systems, methods and analyzers for establishing a secure wireless network in point of care testing |
| USD708203S1 (en) | 2011-07-20 | 2014-07-01 | Zoocytium Holdings, Llc | Display screen with a graphical user interface |
| AT512011A2 (en) * | 2011-10-12 | 2013-04-15 | Greiner Bio One Gmbh | SPECIMEN COLLECTION PROCEDURE FOR IMPROVING THE SAFETY OF A SPECIMEN COLLECTION |
| US10664486B2 (en) * | 2011-12-21 | 2020-05-26 | Laboratory Corporation Of America Holdings | Systems, methods, and media for laboratory testing services |
| US11056229B2 (en) * | 2011-12-21 | 2021-07-06 | Beacon Laboratory Benefit Solutions, Inc. | Systems, methods, and media for laboratory benefit services |
| JP5919059B2 (en) | 2012-03-28 | 2016-05-18 | シスメックス株式会社 | Sample analysis system, sample analysis apparatus, and sample analysis system management method |
| USD737278S1 (en) | 2012-06-28 | 2015-08-25 | Samsung Electronics Co., Ltd. | Portable electronic device with animated GUI |
| US20140081657A1 (en) * | 2012-09-18 | 2014-03-20 | Perkinelmer Health Sciences, Inc. | Apparatus and Methods for Storage and Transfer of Patient Information Using Biological Sample Cards with Short Range Communications |
| US9787815B2 (en) | 2013-01-21 | 2017-10-10 | Cornell University | Smartphone-based apparatus and method |
| CA2901016A1 (en) | 2013-02-18 | 2014-08-21 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
| USD717822S1 (en) | 2013-03-14 | 2014-11-18 | Ijet International, Inc. | Display screen or portion thereof with graphical user interface |
| JP5909480B2 (en) * | 2013-12-25 | 2016-04-26 | シスメックス株式会社 | Specimen test apparatus and test information output method |
| USD762230S1 (en) | 2014-04-23 | 2016-07-26 | Google Inc. | Display panel with an animated computer icon |
| USD778311S1 (en) | 2014-06-23 | 2017-02-07 | Google Inc. | Display screen with graphical user interface for account switching by swipe |
| US20160019349A1 (en) * | 2014-07-16 | 2016-01-21 | Practice Fusion, Inc. | One click lab service sign up |
| USD824417S1 (en) | 2014-08-22 | 2018-07-31 | Adp, Llc | Display screen or portion thereof with graphical user interface |
| USD752624S1 (en) | 2014-09-01 | 2016-03-29 | Apple Inc. | Display screen or portion thereof with graphical user interface |
| USD760742S1 (en) | 2015-03-16 | 2016-07-05 | Nike, Inc. | Display screen with graphical user interface |
| EP3091458B1 (en) * | 2015-05-02 | 2021-02-24 | F. Hoffmann-La Roche AG | Point-of-care testing system |
| USD795917S1 (en) | 2015-05-17 | 2017-08-29 | Google Inc. | Display screen with an animated graphical user interface |
| USD808974S1 (en) | 2015-06-04 | 2018-01-30 | Sentiment 360 Ltd. | Display screen or portion thereof with a transitional graphical user interface |
| USD807376S1 (en) | 2015-06-14 | 2018-01-09 | Google Inc. | Display screen with animated graphical user interface for smart home automation system having a multifunction status |
| USD800163S1 (en) | 2016-04-28 | 2017-10-17 | Microsoft Corporation | Display screen with animated graphical user interface |
| USD824416S1 (en) | 2016-09-09 | 2018-07-31 | Royal Master Grinders, Inc. | Display screen with animated graphical user interface |
| USD818491S1 (en) | 2016-09-30 | 2018-05-22 | Koninklijke Philips N.V. | Display screen with graphical user interface |
| USD839293S1 (en) | 2017-03-28 | 2019-01-29 | Intuit Inc. | Display device with a graphical user interface presenting a countdown timer for connecting with an agent |
| USD826971S1 (en) | 2017-06-09 | 2018-08-28 | Microsoft Corporation | Display screen with graphical user interface |
| USD872102S1 (en) | 2017-08-16 | 2020-01-07 | Intuit Inc. | Display device with graphical user interface having a determinate progress indicator animation |
| USD875751S1 (en) | 2017-08-22 | 2020-02-18 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with transitional graphical user interface |
| USD839888S1 (en) | 2017-08-25 | 2019-02-05 | Samsung Electonics Co., Ltd. | Display screen or portion thereof with graphical user interface |
| AU2018368735A1 (en) * | 2017-11-20 | 2020-04-30 | Siemens Healthcare Diagnostics Inc. | Multiple diagnostic engine environment |
| AU2018367618B2 (en) * | 2017-11-20 | 2020-12-03 | Siemens Healthcare Diagnostics Inc. | User interface for managing a multiple diagnostic engine environment |
| USD849039S1 (en) | 2018-01-04 | 2019-05-21 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with graphical user interface |
| USD845969S1 (en) | 2018-01-05 | 2019-04-16 | Google Llc | Display screen or portion thereof with transitional graphical user interface |
| USD902946S1 (en) | 2019-01-31 | 2020-11-24 | Salesforce.Com, Inc. | Display screen or portion thereof with graphical user interface |
| USD908911S1 (en) * | 2019-05-22 | 2021-01-26 | Siemens Healthcare Diagnostics Inc. | Analyzing instrument and display monitor in combination |
| TWD210298S (en) | 2019-07-24 | 2021-03-11 | 宏達國際電子股份有限公司 | Graphical user interface for a display screen |
| USD946590S1 (en) * | 2020-03-24 | 2022-03-22 | Roche Diabetes Care, Inc. | Display screen with graphical user interface for glucose management |
| JP1684573S (en) | 2020-03-17 | 2021-05-10 | ||
| EP3905002A1 (en) * | 2020-03-23 | 2021-11-03 | F. Hoffmann-La Roche AG | Poct instrument and poct system |
| USD934899S1 (en) | 2020-05-15 | 2021-11-02 | Barel Ip, Inc. | Computing device display screen or portion thereof with a graphical user interface |
| JP1678172S (en) | 2020-06-24 | 2021-02-01 | ||
| USD964381S1 (en) | 2021-01-20 | 2022-09-20 | Beijing Kongming Technology Co., Ltd. | Display screen or portion thereof with a graphical user interface |
| USD978892S1 (en) * | 2021-03-02 | 2023-02-21 | Pece Angelkovski | Display screen with a graphical user interface |
-
2020
- 2020-02-03 MX MX2021009176A patent/MX2021009176A/en unknown
- 2020-02-03 WO PCT/US2020/016352 patent/WO2020163214A1/en not_active Ceased
- 2020-02-03 US US17/310,236 patent/US12167945B2/en active Active
- 2020-02-03 CA CA3128979A patent/CA3128979A1/en active Pending
- 2020-02-03 EP EP20752748.2A patent/EP3921840A4/en active Pending
- 2020-02-03 JP JP2021545817A patent/JP7241189B2/en active Active
- 2020-02-03 AU AU2020219731A patent/AU2020219731A1/en not_active Abandoned
-
2021
- 2021-04-16 US US29/779,118 patent/USD984466S1/en active Active
- 2021-04-16 US US29/779,112 patent/USD993967S1/en active Active
- 2021-04-16 US US29/779,125 patent/USD984467S1/en active Active
- 2021-04-16 US US29/779,114 patent/USD993981S1/en active Active
-
2024
- 2024-11-04 US US18/935,821 patent/US20250057632A1/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170220775A1 (en) * | 2001-11-13 | 2017-08-03 | Dako Denmark A/S | System for tracking biological samples |
| US20090227897A1 (en) * | 2004-12-09 | 2009-09-10 | Koninklijke Philips Electronics N.V. | Patient identification for point of care diagnostics |
| US20130080071A1 (en) * | 2011-09-25 | 2013-03-28 | Theranos, Inc., a Delaware Corporation | Systems and methods for sample processing and analysis |
| US20150209114A1 (en) * | 2014-01-29 | 2015-07-30 | Becton, Dickinson And Company | System and Method for Collection Confirmation and Sample Tracking at the Clinical Point of Use |
| US20170021349A1 (en) | 2014-11-11 | 2017-01-26 | Genmark Diagnostics, Inc. | Redundant identification for sample tracking on a diagnostic device |
| US20160321421A1 (en) * | 2015-05-02 | 2016-11-03 | Roche Diagnostics Operations, Inc. | Point-of-care testing system |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP3921840A4 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022207108A1 (en) * | 2021-03-31 | 2022-10-06 | Cg Test Gmbh | Method for evaluating a test result of a medical test means |
Also Published As
| Publication number | Publication date |
|---|---|
| USD984466S1 (en) | 2023-04-25 |
| EP3921840A4 (en) | 2022-03-23 |
| US20220047355A1 (en) | 2022-02-17 |
| CA3128979A1 (en) | 2020-08-13 |
| JP2022519647A (en) | 2022-03-24 |
| EP3921840A1 (en) | 2021-12-15 |
| AU2020219731A1 (en) | 2021-07-29 |
| MX2021009176A (en) | 2021-09-08 |
| JP7241189B2 (en) | 2023-03-16 |
| USD993981S1 (en) | 2023-08-01 |
| USD993967S1 (en) | 2023-08-01 |
| USD984467S1 (en) | 2023-04-25 |
| US20250057632A1 (en) | 2025-02-20 |
| US12167945B2 (en) | 2024-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250057632A1 (en) | Patient id and sample id workflow methods and apparatus for facilitating diagnostic testing | |
| US20260018296A1 (en) | User interface for managing a multiple diagnostic engine environment | |
| St-Louis | Status of point-of-care testing: promise, realities, and possibilities | |
| EP3822952B1 (en) | System and method for quality assured analytical testing | |
| JP7482952B2 (en) | Multiple Diagnosis Engine Environment | |
| US11169164B2 (en) | System for biological sample collection, examination and reading in quick biochemical tests and data management | |
| WO2024177880A1 (en) | Methods and apparatus for preventing patient and sample mismatch during diagnostic testing | |
| Bhardwaj et al. | Point of Care Testing (POCT) in Clinical Veterinary Biochemistry | |
| US11567093B2 (en) | Biological sample reader for biochemical testing | |
| Wick | Small miracles: point-of-care testing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20752748 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2020219731 Country of ref document: AU Date of ref document: 20200203 Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 3128979 Country of ref document: CA |
|
| ENP | Entry into the national phase |
Ref document number: 2021545817 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2020752748 Country of ref document: EP Effective date: 20210906 |
|
| WWG | Wipo information: grant in national office |
Ref document number: MX/A/2021/009176 Country of ref document: MX |